A gene expression prediction model established using the whole transcriptome association study of blood tissues for PCa cases and controls suggested that the expression level of the SLC39A1 gene in PCa patients was significantly higher than that in the control group [60]. The gene discussed is SLC39A1; the disease is posterior cortical atrophy.